42 completed, 17 terminated, 14 recruiting, 5 withdrawn. 30 Phase 4, 10 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 30 | Completed 20, Terminated 6, Withdrawn 4 |
| Not applicable | 10 | Terminated 5, Completed 2, Active not recruiting 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Seung-Jung Park: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The DECISION-CTO Extended 10 Y Follow-up Coronary Artery Disease | Recruiting | Seung-Jung Park | 840 | 2026-04-01 | 2026-06-24 | |
| IRIS-Coroflex NEO Cohort Coroflex ISAR NEO stent - Coronary Artery Stenosis, Coronary Artery Disease | Recruiting | Seung-Jung Park | 1000 | 2025-01-09 | 2026-06-25 | |
| Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease FFR-Guided PCI, Angiography-Guided PCI - Coronary Artery Disease Left Main, Coronary Artery Disease | Not applicable | Recruiting | Seung-Jung Park | 960 | 2024-04-25 | 2026-06-24 |
| Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice XIENCE Skypoint™ stent - Coronary Artery Disease | Recruiting | Seung-Jung Park | 2000 | 2023-12-14 | 2026-01-02 | |
| Ten-Year Outcomes of Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease coronary stent implantation, bypass grafting - Multivessel Coronary Artery Disease | Completed | Seung-Jung Park | 880 | 2022-05-01 | 2022-08-05 | |
| Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice Xience Sierra stent - Coronary Artery Disease, Coronary Disease | Active not recruiting | Seung-Jung Park | 2000 | 2019-12-23 | 2026-01-02 | |
| IRIS-BioFreedom Cohort in the IRIS-DES Registry BIOFREEDOM™ FAMILY stent - Coronary Stenosis | Terminated | Seung-Jung Park | 218 | 2019-05-20 | 2025-09-30 | |
| Ten-Year Outcomes of PRE-COMBAT Trial Percutaneous coronary intervention, coronary artery bypass graft - Coronary Artery Disease | Completed | Seung-Jung Park | 600 | 2019-05-01 | 2020-06-18 | |
| Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization Hybrid Coronary Revascularization - Percutaneous Coronary Revascularization, Coronary Stenosis | Terminated | Seung-Jung Park | 6 | 2019-04-05 | 2026-04-15 | |
| Percutaneous Device Closure for Significant Paravalvular Leakage After Transcatheter or Surgical Valve Replacement Percutaneous Device Closure: Vascular plug - Cardiac Valves, Heart Valve Diseases | Not applicable | Withdrawn | Seung-Jung Park | 2019-01-31 | 2019-02-01 | |
| IRIS- DESyne X2 in the IRIS-DES Registry DESyne X2 - Coronary Stenosis, Coronary Occlusion | Recruiting | Seung-Jung Park | 1000 | 2018-11-28 | 2026-06-24 | |
| Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice Rotational atherectomy - Atherosclerosis, Coronary, Coronary Stenosis | Recruiting | Seung-Jung Park | 500 | 2018-09-04 | 2026-01-02 | |
| Evaluation of Effectiveness and Safety of Evolut R Valve In Patients With Pure Aortic Regurgitation TAVR with Evolut R valve - Aortic Valve, Aortic Valve Insufficiency | Not applicable | Terminated | Seung-Jung Park | 2 | 2018-08-10 | 2019-02-22 |
| Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-VII: Sirolimus-eluting (Ultimaster) vs. Everolimus-Eluting Stents (Xience) Ultimaster stent, Xience alpine stent - Coronary Artery Disease, Coronary Stenosis | Not applicable | Terminated | Seung-Jung Park | 36 | 2018-07-27 | 2019-09-10 |
| Evaluation of Effectiveness and Safety of Aortic Valve Replacement in Routine Clinical Practice Valve Replacement - Aortic Valve Disease, Aortic Valve Stenosis | Active not recruiting | Seung-Jung Park | 900 | 2018-05-10 | 2026-01-02 | |
| Debulking With Rotational Atherectomy Versus Balloon Angioplasty In Patients With In-stent Restenosis Rotational atherectomy followed by balloon angioplasty, Balloon angioplasty - Coronary Vessels | Not applicable | Completed | Seung-Jung Park | 95 | 2018-05-08 | 2023-01-04 |
| Asan Medical Center Myocardial Infarction Registry Myocardial Infarction, Acute, Coronary Stenosis | Recruiting | Seung-Jung Park | 5000 | 2018-04-27 | 2026-01-02 | |
| Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention PCI - Coronary Vessels | Not applicable | Active not recruiting | Seung-Jung Park | 2008 | 2018-04-12 | 2026-10-16 |
| Pragmatic Trial Comparing Symptom-Oriented Versus Routine Stress Testing in High-Risk Patients Undergoing Percutaneous Coronary Intervention routine stress testing, No Routine stress testing - Coronary Artery Disease With Myocardial Infarction | Not applicable | Completed | Seung-Jung Park | 1700 | 2017-11-15 | 2022-04-05 |
| HOW To Optimally Implant BioResorbable Scaffold - Intravascular Imaging Versus Quantitative Coronary Angiography Guidance quantitative coronary angiography guided Bioresorbable scaffold implantation, imaging guided Bioresorbable scaffold implantation - Coronary Stenosis | Not applicable | Terminated | Seung-Jung Park | 84 | 2017-09-29 | 2022-07-08 |
Showing 20 of 82. Sign in to see all of them.
Coronary Artery Disease (58) · Coronary Stenosis (11) · Coronary Disease (10) · Aortic Valve Stenosis (4) · Cardiovascular Diseases (3) · Acute Coronary Syndrome (2) · Angina Pectoris, Variant (2) · Coronary Occlusion (2) · Death (2) · Diabetes Mellitus (2) · Heart Diseases (2) · Heart Valve Diseases (2) · Myocardial Infarction (2) · Myocardial Ischemia (2) · Angina Pectoris (1)
Clopidogrel (8) · Percutaneous Coronary Intervention (7) · Aspirin (5) · Coronary Artery Bypass (5) · Transcatheter Aortic Valve Replacement (3) · Angioplasty, Balloon (2) · Paclitaxel (2) · Sirolimus (2) · Ticagrelor (2) · zotarolimus (2) · Atherectomy, Coronary (1) · Atorvastatin (1) · Cardiac Rehabilitation (1) · Cilostazol (1) · Medically Underserved Area (1)
South Korea (82) · Taiwan (6) · Thailand (5) · China (4) · India (3) · Japan (3) · Malaysia (3) · Indonesia (2) · Hong Kong (1) · New Zealand (1) · Singapore (1) · United States (1)
Ki Bae Seung, MD, PhD (6) · Duk-woo Park, MD (4) · Gerald Yong, MD (2) · Corrado Tamburino, MD (1) · Edgar Tay, MD (1) · Fabian Nietlispach, MD, PhD (1) · Jeroen J. Bax, MD, PhD (1) · John G. Webb, MD (1) · Kentaro Hayashida, MD (1) · Marie-Claude Morice, MD (1) · Paul Hsien Li Kao, MD (1)
PMID 38199751, PMID 20231231, PMID 27491605, PMID 28495897, PMID 32223567, PMID 34238026, PMID 36121700, PMID 40368452, PMID 20883925, PMID 21364151, PMID 21463149, PMID 22017935, PMID 22814775, PMID 23048051, PMID 23078732, PMID 23787231, PMID 24092248, PMID 24097439, PMID 24823426, PMID 25774645, PMID 25787197, PMID 26434510, PMID 27081016, PMID 27151607, PMID 27609682, PMID 27609817, PMID 27651390, PMID 28356440, PMID 28679524, PMID 28701487, PMID 28851731, PMID 29447782, PMID 29471933, PMID 29529177, PMID 29622168, PMID 29895713, PMID 30261236, PMID 30745256, PMID 30813758, PMID 31553203, PMID 32029254, PMID 32085865, PMID 32310027, PMID 32310851, PMID 32345039, PMID 32473888, PMID 32871327, PMID 32891400, PMID 32943156, PMID 34227392